←Back to Expert Scholars
Translational Medicine / 转化医学Emerging Lung Targets
Benjamin Levy
MD
🏢Johns Hopkins Sidney Kimmel Cancer Center🌐USA
Clinical Director of Medical Oncology
42
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Benjamin Levy leads thoracic medical oncology at Johns Hopkins and is an advocate for expanded biomarker testing. He has contributed to trials establishing trastuzumab deruxtecan in HER2-mutant NSCLC. His work bridges precision oncology advances with community practice implementation.
Share:
🧪Research Fields 研究领域
HER2-mutant NSCLC
Liquid biopsy
Trastuzumab deruxtecan
Precision oncology
Community oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Benjamin Levy 的研究动态
Follow Benjamin Levy's research updates
留下邮箱，当我们发布与 Benjamin Levy（Johns Hopkins Sidney Kimmel Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment